Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Cigna Corp

Healthcare US CI

290.49USD
0.88(0.30%)

Last update at 2026-06-09T16:00:00Z

Day Range

289.38292.77
LowHigh

52 Week Range

236.87342.75
LowHigh

Fundamentals

  • Previous Close 289.61
  • Market Cap73911.04M
  • Volume442567
  • P/E Ratio12.47
  • Dividend Yield2.16%
  • EBITDA12047.00M
  • Revenue TTM274899.99M
  • Revenue Per Share TTM1030.58
  • Gross Profit TTM 25560.00M
  • Diluted EPS TTM22.19

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 7593.00M 5269.00M 5513.00M 8353.00M 6782.00M
Minority interest -331.00000M -344.00000M -159.00000M 78.00M 50.00M
Net income 5957.00M 3434.00M 5164.00M 6668.00M 5365.00M
Selling general administrative 14617.00M 14844.00M 14822.00M 12738.00M 12242.00M
Selling and marketing expenses - - - - -
Gross profit 25986.00M 25964.00M 25177.00M 148436.00M 140710.00M
Reconciled depreciation 2775.00M 2775.00M 3005.00M 2937.00M 2923.00M
Ebit 8974.00M 9692.00M 9034.00M 9503.00M 8352.00M
Ebitda 11607.00M 11446.00M 10846.00M 12440.00M 11275.00M
Depreciation and amortization 2633.00M 1754.00M 1812.00M 2937.00M 2923.00M
Non operating income net other - - - 434.00M -1349.00000M
Operating income 9129.00M 9417.00M 8536.00M 9503.00M 8352.00M
Other operating expenses 265823.00M 237704.00M 186729.00M 171668.00M 167490.00M
Interest expense 1381.00M 1435.00M 1446.00M 1228.00M 1208.00M
Tax provision 1493.00M 1491.00M 141.00M 1607.00M 1367.00M
Interest income 1432.00M 3990.00M 1524.00M 1228.00M 1208.00M
Net interest income -1408.00000M -1435.00000M -1410.00000M -1228.00000M -1208.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1345.00M 1491.00M 141.00M 1607.00M 1367.00M
Total revenue 274952.00M 247121.00M 195265.00M 180642.00M 174272.00M
Total operating expenses 16857.00M 16547.00M 16641.00M 13186.00M -288953.00000M
Cost of revenue 248966.00M 221157.00M 170088.00M 32206.00M 33562.00M
Total other income expense net -1536.00000M -4148.00000M -3023.00000M -1150.00000M 121463.00M
Discontinued operations - - - - -
Net income from continuing ops 6288.00M 3778.00M 5451.00M 6668.00M 5415.00M
Net income applicable to common shares 5957.00M 3434.00M 5164.00M 6668.00M 5365.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 157919.00M 155881.00M 152761.00M 143932.00M 154889.00M
Intangible assets 28560.00M 32243.00M 30863.00M 32492.00M 34102.00M
Earning assets - - - - -
Other current assets 4032.00M 9898.00M 6162.00M 2201.00M 12260.00M
Total liab 116045.00M 114638.00M 106410.00M 98981.00M 107705.00M
Total stockholder equity 41713.00M 41033.00M 46223.00M 44872.00M 47112.00M
Deferred long term liab - - - 7751.00M 8346.00M
Other current liab 45091.00M 17185.00M 37388.00M -10768.00000M -9200.00000M
Common stock 4.00M 4.00M 4.00M 4.00M 4.00M
Capital stock 4.00M 4.00M 4.00M 4.00M 4.00M
Retained earnings 47865.00M 43519.00M 41652.00M 37874.00M 32593.00M
Other liab - - - 29306.00M 33008.00M
Good will 44924.00M 44370.00M 44259.00M 45811.00M 45811.00M
Other assets 14499.00M 14442.00M - 32160.00M 43965.00M
Cash 7676.00M 7550.00M 7822.00M 5924.00M 5081.00M
Cash and equivalents 7676.00M 7550.00M - 5924.00M 5081.00M
Total current liabilities 56342.00M 57979.00M 48716.00M 10768.00M 9200.00M
Current deferred revenue - - - - -
Net debt 23787.00M 24422.00M 23108.00M 25169.00M 28589.00M
Short term debt 592.00M 3035.00M 2775.00M 2993.00M 2545.00M
Short long term debt 592.00M 3035.00M 2775.00M 2993.00M 2545.00M
Short long term debt total 31463.00M 31972.00M 30930.00M 31093.00M 33670.00M
Other stockholder equity -3350.00000M -149.00000M 6431.00M 8389.00M 15399.00M
Property plant equipment 3651.00M 3654.00M - 4149.00M 3692.00M
Total current assets 47814.00M 48870.00M 37351.00M 28790.00M 26096.00M
Long term investments 12175.00M 665.00M 925.00M 16288.00M 18438.00M
Net tangible assets - - - -33365.00000M -32801.00000M
Short term investments 970.00M 665.00M 925.00M 905.00M 920.00M
Net receivables 28768.00M 24065.00M 17722.00M 21961.00M 20095.00M
Long term debt 30871.00M 28937.00M 28155.00M 28034.00M 31097.00M
Inventory 7338.00M 6692.00M 5645.00M 4777.00M 3722.00M
Accounts payable 10659.00M 37759.00M 8553.00M 7775.00M 6655.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 13.00M 18.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2806.00000M -2341.00000M -1864.00000M -1395.00000M -884.00000M
Additional paid in capital - - - - -
Common stock total equity - - - 4.00M 4.00M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 37874.00M 32593.00M
Treasury stock - - - -21844.00000M -14175.00000M
Accumulated amortization - - - - -
Non currrent assets other 14499.00M 14442.00M 18238.00M -82982.00000M -84828.00000M
Deferred long term asset charges - - - - -
Non current assets total 110105.00M 107011.00M 115410.00M 82982.00M 84828.00M
Capital lease obligations - - - - -
Long term debt total 30871.00M 28937.00M - 28100.00M 31125.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -4552.00000M -2102.00000M -5174.00000M -587.00000M -765.00000M
Change to liabilities - - - 1865.00M -77.00000M
Total cashflows from investing activities -4407.00000M -2102.00000M - 3098.00M -3611.00000M
Net borrowings -667.00000M 1060.00M - -500.00000M 800.00M
Total cash from financing activities -6421.00000M -7647.00000M -4294.00000M -11240.00000M -8212.00000M
Change to operating activities - - - 2338.00M 2605.00M
Net income 6288.00M 3778.00M 5164.00M 6746.00M 5415.00M
Change in cash 126.00M 594.00M 2361.00M 428.00M -4697.00000M
Begin period cash flow 7550.00M 8337.00M 5976.00M 5548.00M 10245.00M
End period cash flow 7676.00M 8931.00M 8337.00M 5976.00M 5548.00M
Total cash from operating activities 9601.00M 10363.00M 11813.00M 8656.00M 7191.00M
Issuance of capital stock 203.00M 305.00M 185.00M 389.00M 326.00M
Depreciation 2775.00M 2775.00M 3035.00M 2937.00M 2923.00M
Other cashflows from investing activities -3482.00000M -838.00000M - 4393.00M -3611.00000M
Dividends paid 1611.00M 1567.00M 1450.00M 1384.00M 1341.00M
Change to inventory -646.00000M -1032.00000M -868.00000M -1055.00000M 143.00M
Change to account receivables -4630.00000M -7854.00000M -2202.00000M -2275.00000M -3232.00000M
Sale purchase of stock -3621.00000M -7034.00000M -2284.00000M -7607.00000M -7742.00000M
Other cashflows from financing activities -726.00000M -411.00000M -469.00000M -2138.00000M 999.00M
Change to netincome - - - -1647.00000M -225.00000M
Capital expenditures 1212.00M 1406.00M 1573.00M 1295.00M 1154.00M
Change receivables - - - -2275.00000M -3232.00000M
Cash flows other operating - - - 2085.00M 2027.00M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - 514.00M -4632.00000M
Change in working capital 201.00M 1192.00M 3488.00M 620.00M -872.00000M
Stock based compensation - 308.00M 286.00M 264.00M 268.00M
Other non cash items 11.00M 2713.00M 1499.00M -1431.00000M 141.00M
Free cash flow 8389.00M 8957.00M 10240.00M 7361.00M 6037.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
CI
Cigna Corp		 0.88 0.30% 290.49 12.47 9.12 0.27 1.75 0.35
UNH
UnitedHealth Group Incorporated		 5.19 1.28% 411.76 22.57 18.38 1.33 5.65 1.38 13.97
CVS
CVS Health Corp		 -0.025 0.03% 97.06 55.65 10.80 0.25 1.32 0.42 17.09
ELV
Elevance Health Inc		 2.47 0.59% 420.62 13.02 12.47 0.36 1.60 0.47
HUM
Humana Inc		 1.03 0.29% 357.01 19.16 14.60 0.56 3.37 0.53

Reports Covered

Stock Research & News

View All

Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Cigna Corp

900 Cottage Grove Road, Bloomfield, CT, United States, 06002

Key Executives

Name Title Year Born
Mr. David Michael Cordani Pres, CEO & Chair of the Board 1965
Mr. Brian C. Evanko Exec. VP & CFO 1977
Ms. Nicole Susan Jones Exec. VP & Gen. Counsel 1970
Mr. Eric Paul Palmer Pres & CEO of Evernorth 1976
Mr. Paul Sanford Exec. VP of Operations 1968
Ms. Mary Terese Agoglia Hoeltzel CPA Sr. VP of Tax & Chief Accounting Officer NA
Ms. Noelle K. Eder Exec. VP & Global Chief Information Officer 1970
Mr. Ralph Giacobbe Sr. VP & Head of Investor Relations NA
Mr. Everett Neville Exec. VP of Strategy, Corp. Devel. & Solutions 1965
Ms. Cynthia Ryan Exec. VP & Chief HR Officer 1974

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.